SS
Sathgen Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MSP008-22 | Triple‑negative breast cancer and other solid tumors | Phase 1 |
| SBGBL | Multiple solid tumors (TNBC, prostate, oral, glioblastoma, hepatic, cervical, colon, lung) | Preclinical |
| LSPGBL | Multiple solid tumors (TNBC, prostate, oral, glioblastoma, hepatic, cervical, colon, lung) | Preclinical |
| METGBL | Various solid tumors (tyrosine kinase driven) | Preclinical |